Literature DB >> 8505193

Impact of influenza on mortality in relation to age and underlying disease, 1967-1989.

M J Sprenger1, P G Mulder, W E Beyer, R Van Strik, N Masurel.   

Abstract

Based on data from the Dutch Central Bureau of Statistics, the impact of influenza on mortality in The Netherlands was estimated for a 22.5-year period (1967-1989) in four age groups and three entities of disease, using Poisson regression techniques. Our analysis suggests that, on average, more than 2000 people died from influenza in The Netherlands each year, but in only a fraction of these deaths was influenza recognized as the cause of death. For each case of death registered as caused by influenza (registered influenza mortality), 2.6 additional cases of death registered as due to causes other than influenza, nevertheless, were influenza-related (non-registered influenza mortality). Therefore, the overall impact of influenza on mortality is estimated to be greater than registered influenza mortality by a factor of 3.6. Those under 60 years of age accounted for 5% of all non-registered influenza deaths, whereas people aged 60-69, 70-79 years and > 80 years accounted for 12%, 29% and 54% of such deaths, respectively. When extrapolating the figures for the Dutch population of 1989, we could attribute, on average per season-year, 82 deaths per 100,000 people > 60 years, 143 in people > 70 years, and 280 in people > 80 years. Of all non-registered influenza cases of death, 47% were estimated to occur in people with heart disease as a primarily reported cause of death, 23% in those with lung disease, and 30% in those with other diseases. This study stresses the serious effects of influenza, mainly in the elderly (95% of non-registered influenza mortality).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Keywords:  Adult; Age Factors; Aged; Causes Of Death; Communicable Diseases; Demographic Factors; Developed Countries; Diseases; Epidemiologic Methods; Europe; Infections; Mortality; Netherlands; Population; Population Characteristics; Population Dynamics; Research Methodology; Western Europe

Mesh:

Year:  1993        PMID: 8505193     DOI: 10.1093/ije/22.2.334

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  47 in total

1.  Immune response to influenza vaccination in an elderly population.

Authors:  Lidia B Brydak; Magdalena Machała; Jolanta Myśliwska; Andrzej Myśliwski; Piotr Trzonkowski
Journal:  J Clin Immunol       Date:  2003-05       Impact factor: 8.317

2.  Quantifying influenza vaccine efficacy and antigenic distance.

Authors:  Vishal Gupta; David J Earl; Michael W Deem
Journal:  Vaccine       Date:  2006-01-19       Impact factor: 3.641

Review 3.  KLRG1--more than a marker for T cell senescence.

Authors:  Sian M Henson; Arne N Akbar
Journal:  Age (Dordr)       Date:  2009-12

4.  Influenza-related excess mortality, Austria 2001 till 2009.

Authors:  Hung-Wei Kuo; Daniela Schmid; Yu-Lun Liu; Peter Lachner; Franz Allerberger
Journal:  Wien Klin Wochenschr       Date:  2011-08-23       Impact factor: 1.704

Review 5.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

6.  Monitoring mortality as an indicator of influenza in Catalonia, Spain.

Authors:  A Domínguez; P Muñoz; A Martínez; A Orcau
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

Review 7.  Economic evaluation of influenza vaccination. Assessment for The Netherlands.

Authors:  M J Postma; J M Bos; M van Gennep; J C Jager; R Baltussen; M J Sprenger
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

8.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

9.  Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents.

Authors:  Vincenzo Baldo; Tatjana Baldovin; Michele Pellegrini; Gabriele Angiolelli; Silvia Majori; Annarosa Floreani; Marta Cecilia Busana; Chiara Bertoncello; Renzo Trivello
Journal:  Clin Dev Immunol       Date:  2010-03-29

10.  Pandemic influenza and healthcare demand in the Netherlands: scenario analysis.

Authors:  Marianne L L van Genugten; Marie-Louise A Heijnen; Johannes C Jager
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.